Gene | Oncogene | TSG | Type of alteration | Patient | Prediction of functional consequences | Occurrence of genomic alterations previously reported in phyllodes tumors | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
General classification | Details | VUS | 1 | 2 | FATHMM-XF | Mutation Taster2 | Specific alteration | Other alterations | Type of tissue | |||
APC | + | non-syn. SNV | p.R230H | + | P1, M1 | 0.98, pathogenic | Disease causing | NR | NR | |||
ARID1A | + | non-fs deletion | p.A345_A349del | M1 | – | Polymorphisma | NR | One case, non-syn. SNV [18] | P benign | |||
non-fs insertion | p.A247_G248insA | + | P2, R2 | – | Polymorphism | NR | ||||||
BCOR | + | splicing, stop gain | p.R1031fs*23 | P2 | – | Disease causing | NR | P borderline, malignant | ||||
BRIP1 | + | non-syn. SNV | p.M1V | P1, M1 | 0.02, benign | Polymorphism | NR | NR | ||||
CARD11 | + | non-syn. SNV | p.S925C | + | P2, R2 | NA | Polymorphism | NR | P malignant | |||
CASP8 | + | non-syn. SNV | p.F18L | + | P1 | NA | Polymorphism | NR | NR | |||
CDK4 | + | non-syn. SNV | p.T102K | + | P1, M1 | NA | Disease causing | NR | NR | |||
EGFR | + | non-syn. SNV | p.Q432K | P2 | 0.71, pathogenic | Disease causing | NR | P malignant | ||||
amplification | copy no. = 11 | R2 | – | – | Several cases | P, M malignant | ||||||
GRIN2A | + | + | non-syn. SNV | p.T141K | + | M1 | NA | Polymorphism | NR | NR | ||
IGF1R | + | amplification | copy no. = 6 | P2 | – | – | Two cases [11] | P malignant | ||||
copy no. = 19 | R2 | – | – | |||||||||
KIT | + | amplification | copy no. = 21 | P2 | – | – | One case [13] | NR | P malignant | |||
copy no. = 27 | R2 | – | – | |||||||||
MED12 | + | non-syn. SNV | p.G44V | P1, M1 | 0.95, pathogenic | Disease causing | P, R, M all grades | |||||
KMT2D (MLL2) | + | fs deletion, stop gain | p.E2603fs*88 | P1, M1 | – | Disease causing | NR | P, M all grades | ||||
stop gain | p.Q3293* | NA | Disease causing | NR | ||||||||
MYC | + | amplification | copy no. = 33 | P2 | – | – | NR | P malignant | ||||
copy no. = 44 | R2 | – | – | |||||||||
PAX5 | + | + | non-syn. SNV | p.S213L | + | P2, R2 | 0.89, pathogenic | Disease causing | NR | One case [38] | P, benign | |
PDGFRA | + | amplification | copy no. = 24 | P2 | – | – | NR | R malignant | ||||
amplification | copy no. = 35 | R2 | – | – | ||||||||
RB1 | + | fs deletion, stop gain | I124fs*6 | P2 | – | Disease causing | NR | Several cases | P, M borderline malignant | |||
stop gain | p. Y321* | P2 | NA | Disease causing | ||||||||
TERT | + | + | promoter | c.-124C > T | P1, M1 | NA | NA | Hotspot | ||||
P, R all grades | ||||||||||||
TP53 | + | non-syn. SNV | p.R249S | P1, M1 | NA | Disease causing | NR, c.747G > C | P, R, M mostly malignant | ||||
non-syn. SNV | G262V | P2, R2 | 1.00, pathogenic | Disease causing | NR | |||||||
non-syn. mutation | p.Q_S6 > HP | R2 | – | Polymorphism | NR | |||||||
deletion | exons 2–9 | P2, R2 | – | – | NR | Deletion of gene [10] | P, distant malignant |